News

Bristol-Myers enters option deal to acquire F-star Alpha and FS102

28-10-2014

US pharma major Bristol-Myers Squibb has entered into an agreement that provides it with the exclusive…

BiotechnologyBristol-Myers SquibbF-star AlphaFS102Mergers & AcquisitionsOncology

Five Prime rockets on immuno-oncology deal with Bristol-Myers Squibb

Five Prime rockets on immuno-oncology deal with Bristol-Myers Squibb

17-03-2014

Shares of Five Prime Therapeutics leapt 15% to $21.48 in early trading, after the company said it has…

Bristol-Myers SquibbFive Prime TherapeuticsLicensingMergers & AcquisitionsOncologyPharmaceutical

Celgene buys rival Gloucester for $640 million, gaining rights to Istodax; Allos defends price of Folotyn

08-12-2009

Celgene Corp says it has entered into a definitive agreement to acquire fellow USA-based rival acquire…

Amino AcidsBristol-Myers SquibbcetuximabErbituxFolotynInjectionLillyMergers & AcquisitionsNorth AmericaOncologyPharmaceuticalPhysostigmine SalicylatePralatrexate Solution for Intravenous InjectiPricing

Back to top